Amazon is a company that’s loved by many consumers, but not so much by traditional retailers or certain IT-based companies. It’s already made news by announcing opening pickup centers where customers can go get products they ordered, but they’re also now looking to offer new healthcare services. It’s a complex service with a lot of angles to it, but the way Paul Mampilly describes it is that they are targeting existing healthcare company stocks and causing their prices to fall while also looking to get new deals with pharmaceuticals and potentially cut the middle out of its sales where they would usually otherwise go through en-route to drug store shelves. While consumers may enjoy lower prices for this, Mampilly says this could cause a major disruption in the stock market and healthcare stock holders could see their value go dramatically down. Mampilly also says while it may look like a deals are there to buy low-priced healthcare stocks, he warns against it.
Bitcoin is up an astonishing 1,172% in the last 12 months, hitting a high of more than $11,000.
— Paul Mampilly (@Paul_M_Guru) November 30, 2017
Paul Mampilly is a newsletter author and personal investor who moved away from the big money on Wall Street to tell people how to invest the right way on Main Street. His newsletters are published at Banyan Hill and they all focus on how to start and manage an investment portfolio without going through the big banks or brokers as was traditionally the case. The investing information Mampilly provides has been reviewed as easy to understand, and most of his followers have reported high earnings on stocks they’ve purchased thanks to Mampilly’s words.
Paul Mampilly came to the US back in the mid-1980s after his family from India was able to support his college education there. He graduated from Montclair State University and started learning the basics of investment advice as a researcher for Deutsche Bank. He became a full-time accounts manager at ING and had built a great reputation as an advisor for clients at Banker’s Trust. Mampilly took his investment knowledge to the next level as a managing director for the Kinetics International hedge fund during which he oversaw over $25 billion in assets under management which made investment returns over 26%. Mampilly also won the Templeton Foundation award in 2009 when he gained 76% on a $50 million investment without shorting any stocks during the recession, and he also bought several early stage shares in Sarepta Therapeutics which Mampilly surprised many investors with how fast he predicted it would grow. He joined Banyan Hill in 2016 and saw his subscriber base grow to 60,000 within months. His facebook page